Alpha-fetoprotein and modified response evaluation criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation-Reference-Cited by-同舟云学术

Alpha-fetoprotein and modified response evaluation criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation

Published:2013-09-24 Issue:10 Volume:19 Page:1108-1118
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Lai Quirino¹²,Avolio Alfonso W.³,Graziadei Ivo⁴,Otto Gerd⁵,Rossi Massimo²,Tisone Giuseppe⁶,Goffette Pierre¹,Vogel Wolfgang⁴,Pitton Michael B.⁵,Lerut Jan¹,

Affiliation:

1. Starzl Unit of Abdominal Transplantation, St. Luc University Hospital; Catholic University of Louvain; Brussels Belgium

2. Department of General Surgery and Organ Transplantation, Umberto I Hospital; Sapienza University; Rome Italy

3. Liver Unit, Department of Surgery, Agostino Gemelli Hospital; Catholic University; Rome Italy

4. Gastroenterology and Hepatology, Department of Internal Medicine II; Innsbruck Medical University; Innsbruck Austria

5. Department of Transplantation and Hepatobiliary Surgery; University of Mainz; Mainz Germany

6. Department of Transplant Surgery, Polyclinic Tor Vergata Foundation; Tor Vergata University; Rome Italy

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.23706/fullpdf

Reference41 articles.

1. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

2. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience;Mazzaferro;Liver Transpl,2011

3. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival;Yao;Hepatology,2001

4. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis;Mazzaferro;Lancet Oncol,2009

5. Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions;Schmitt;Ann Hepatol,2010

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV);Zeitschrift für Gastroenterologie;2024-09

2. Efficacy of CalliSpheres ^® drug-loaded microspheres combined with doxorubicin in hepatocellular carcinoma;Scandinavian Journal of Gastroenterology;2024-08-18

3. hepatocellular carcinoma and liver transplantation;Liver Cancer - Multidisciplinary Approach;2024-07-22

4. Development of a nomogram for predicting liver transplantation prognosis in hepatocellular carcinoma;World Journal of Gastroenterology;2024-06-07

5. Liver Transplantation: An Updated Criteria Selection for HCC;Liver Transplantation - Challenges and Opportunities;2024-04-05